Tumour-seeding: a rare complication of ablative therapy for clinically localised renal cell carcinoma.

Arash Akhavein, Molly M. Neuberger, Philipp Dahm

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Current evidence-based clinical practice guidelines identify surgical resection as the recommended treatment of small renal masses. Ablative approaches such as laparoscopic and percutaneous cryoablation and radiofrequency ablation offer the promise of complete tumour destruction by a less-invasive approach with regard to outcomes such as anaesthesia requirements, blood loss, length of stay and time to recovery, making them appealing to patients. However, evidence of therapeutic benefits, harms and costs for these methods remains limited. We report a case of applicator tract seeding by tumour following percutaneous cryoablation of renal cell carcinoma; a rare and potentially under-reported, yet catastrophic complication of ablative therapy.

Original languageEnglish (US)
JournalBMJ Case Reports
DOIs
StatePublished - 2012

PubMed: MeSH publication types

  • Case Reports
  • Journal Article

Fingerprint Dive into the research topics of 'Tumour-seeding: a rare complication of ablative therapy for clinically localised renal cell carcinoma.'. Together they form a unique fingerprint.

Cite this